Back
Supernus Pharmaceuticals Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
SUPN
Supernus Pharmaceuticals
Last Price:
$31.79
Seasonality Move:
13.42%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Supernus Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 23.6% based on the past 12 years of stock performance.
-
Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Supernus Pharmaceuticals Stock Undervalued?The current Supernus Pharmaceuticals [SUPN] share price is $30.64. The Score for SUPN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
SUPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 23.6% based on the past 12 years of stock performance.
Supernus Pharmaceuticals Stock Rating
Sell
40
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals overpriced?
-
Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Supernus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
40.28
52-Week Low:
25.53
Prediction Charts
Market Cap:
1.7B
Price in USD:
30.64
Volume:
641.5K
Beta:
1.09
Technical Analysis
SMA50:
34.50
SMA100:
35.64
SMA200:
33.55
52-Wk Change:
-2.51%
Stock Predictions
-
Is Supernus Pharmaceuticals stock public?Yes, Supernus Pharmaceuticals is a publicly traded company.
-
What is the Supernus Pharmaceuticals stock quote today?The Supernus Pharmaceuticals stock price is 30.64 USD today.
-
How to buy Supernus Pharmaceuticals stock online?You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-20 | 31.69 | 32.32 | 32.38 | 31.69 |
| Mar-21 | 31.97 | 32.15 | 32.90 | 31.97 |
| Mar-24 | 31.97 | 32.70 | 32.89 | 31.81 |
| Mar-25 | 32.54 | 33.05 | 33.56 | 32.47 |
| Mar-26 | 33.06 | 32.33 | 33.50 | 32.12 |
| Mar-27 | 32.39 | 32.42 | 32.75 | 31.74 |
| Mar-28 | 32.46 | 32.29 | 32.46 | 32.10 |
| Mar-31 | 32.11 | 32.75 | 32.87 | 31.64 |
| Apr-1 | 32.48 | 31.68 | 32.66 | 31.38 |
| Apr-2 | 31.42 | 32.82 | 32.93 | 31.13 |
| Apr-3 | 32.01 | 32.49 | 32.84 | 32.01 |
| Apr-4 | 31.68 | 32.74 | 33.35 | 31.43 |
| Apr-7 | 32.15 | 32.27 | 34.26 | 31.97 |
| Apr-8 | 32.75 | 30.64 | 33.14 | 30.24 |
Supernus Pharmaceuticals Earnings
Supernus Pharmaceuticals Earnings Report: Per Share Supernus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals Forecast Revenue Growth
Supernus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.91 per share, and an increase next year of $0.58 per share.
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.